Paris-based @SofinnovaVC , a life sciences investor, has closed its #oversubscribed Sofinnova MD Start IV fund at €82 million. 🇫🇷 🩺 🚀 https://t.co/n1G2IBeZ...

@EU_Startups

prin X

Paris-based @SofinnovaVC , a life sciences investor, has closed its #oversubscribed Sofinnova MD Start IV fund at €82 million. 🇫🇷 🩺 🚀

https://t.co/n1G2IBeZap